At the time of writing, Bristol-Myers Squibb Co [BMY] stock is trading at $49.61, down -1.18%. An important factor to consider is whether the stock is rising or falling in short-term value. The BMY shares have gain 1.89% over the last week, with a monthly amount drifted -16.69%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Cantor Fitzgerald started tracking the stock with Neutral rating on April 22, 2025, and set its price target to $55. On December 16, 2024, upgrade upgraded it’s rating to Buy but maintained its price target of $70 on the stock. Wolfe Research initiated its recommendation with a Peer Perform. Daiwa Securities upgraded its rating to Outperform for this stock on November 13, 2024. In a note dated November 12, 2024, Leerink Partners upgraded an Outperform rating on this stock but restated the target price of $73.
For the past year, the stock price of Bristol-Myers Squibb Co fluctuated between $39.35 and $63.33. Currently, Wall Street analysts expect the stock to reach $64.67 within the next 12 months. Bristol-Myers Squibb Co [NYSE: BMY] shares were valued at $49.61 at the most recent close of the market. An investor can expect a potential return of 30.36% based on the average BMY price forecast.
Analyzing the BMY fundamentals
According to Bristol-Myers Squibb Co [NYSE:BMY], the company’s sales were 47.64B for trailing twelve months, which represents an -5.60% plunge. Gross Profit Margin for this corporation currently stands at 0.66% with Operating Profit Margin at 0.18%, Pretax Profit Margin comes in at 0.13%, and Net Profit Margin reading is 0.11%. To continue investigating profitability, this company’s Return on Assets is posted at 0.06, Equity is 0.32 and Total Capital is 0.13. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of2.95.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 48.81 points at the first support level, and at 48.00 for the second support level. However, for the 1st resistance point, the stock is sitting at 50.30, and for the 2nd resistance point, it is at 50.98.
Ratios To Look Out For
It is important to note that Bristol-Myers Squibb Co [NYSE:BMY] has a current ratio of 1.28. On the other hand, the Quick Ratio is 1.17, and the Cash Ratio is 0.45. Considering the valuation of this stock, the price to sales ratio is 2.12, the price to book ratio is 5.81 and price to earnings (TTM) ratio is 18.63.
Transactions by insiders
Recent insider trading involved Hirawat Samit, EVP,Chief Med.Offr.,Drug Dev., that happened on Apr 25 ’25 when 4250.0 shares were purchased. Chief Executive Officer, BOERNER CHRISTOPHER S. completed a deal on Feb 20 ’25 to buy 2000.0 shares. Meanwhile, EVP,Chief Med.Offr.,Drug Dev. Hirawat Samit bought 1823.0 shares on Feb 14 ’25.
